Trade VRCA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Verrica Pharmaceuticals Inc. (VRCA) is trading at US$5.33, up 5.07% today as of Aug 28, 13:00 EDT. The company has a market capitalisation of US$82.8M. Over the past 52 weeks, VRCA has traded between US$3.28 and US$9.82. On Syfe you can trade VRCA with $0 commission and add it to your watchlist.
| Previous close | US$5.07 |
|---|---|
| Market cap | US$82.8M |
| 52-week range | US$3.28 – US$9.82 |
| Volume | 532.64K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Year: 2018
Verrica Pharmaceuticals Signs Distribution Deal With Medomie for Molluscum Treatment
Jul 21, 12:42 PM · MT Newswires
Verrica Pharmaceuticals' Doses First US Patient in Phase 3 Trial Evaluating Ycanth to Treat Common Warts
Jun 22, 12:50 PM · MT Newswires
Verrica Reports Acceptance of Late-Breaking VP-315 Abstract for Basal Cell Carcinoma
Apr 9, 9:33 PM · MT Newswires
Verrica Pharmaceuticals Inc. (VRCA) stock is trading at US$5.33, +5.07% from the previous close of US$5.07.
The market cap for Verrica Pharmaceuticals Inc. (VRCA) stock is approximately US$82.8M.
The 52-week high for Verrica Pharmaceuticals Inc. (VRCA) stock is US$9.82.
The 52-week low for Verrica Pharmaceuticals Inc. (VRCA) stock is US$3.28.
Verrica Pharmaceuticals Inc. (VRCA) does not currently pay a dividend.
Stay on top of VRCA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
